A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants
Status:
Recruiting
Trial end date:
2021-10-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the rate and extent of absorption of macitentan
following administration of a single oral dose of macitentan formulated as final market image
(FMI) (test), compared to macitentan as the clinical service formulation (CSF) under fasted
conditions in healthy adult participants.